Sandra Leung, one of the longest-serving legal chiefs in the pharmaceutical industry, plans to retire from Bristol Myers Squibb in 2025 after nearly 33 years with the company.
Leung will be succeeded by Cari Gallman, the company’s executive vice president of corporate affairs, Bristol Myers CEO Chris Boerner told employees on Wednesday.
